Page last updated: 2024-08-22

camptothecin and harmine

camptothecin has been researched along with harmine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajitha, A; Akunuri, R; Kamal, A; Kovvuri, J; Nagaraju, B; Nagesh, N; Nayak, VL; Rao, MPN1
Liu, Y; Xu, Z; Zhao, SJ1
Ma, Y; Wink, M1

Reviews

1 review(s) available for camptothecin and harmine

ArticleYear
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles

2019

Other Studies

2 other study(ies) available for camptothecin and harmine

ArticleYear
Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antineoplastic Agents; Binding Sites; Carbolines; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Photosensitizing Agents; Structure-Activity Relationship; Topoisomerase I Inhibitors

2018
The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells.
    Phytotherapy research : PTR, 2010, Volume: 24, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Harmine; Humans; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins

2010